Strategy

Epoch 17: Fibrosis- From Basics to Breakthroughs

Approved Products, Competitive Intensity, Deal Comps

9 hrs ago •

Epoch 16: Engineering Your Body's Own Defense: How Cell Therapy Fights Autoimmunity

Future Treatment Algorithms, CAR-T, T Cell Engagers

Apr 21 •

Epoch 15: US BioHub History

Biotech Bay, Genetown, Biotech Beach & Beyond

Apr 14 •

Epoch 14: Peak Sales Rules Everything Around Me

New Drug Approvals Up, Average Peak Year Sales Down?

Apr 7 •

Epoch 13: The Approval Equation - Unpacking This Year's Drug Approval Trends

First in Class vs Best in Class, Pharma vs Biotech, Accelerated Regulatory Paths

Mar 31 •

Epoch 12: Clinical Development Operations Tends

Trial Start Trends, Modalities, Therapeutic Areas

Mar 24 •

Epoch 11: Investing in Innovation: A Look at Biopharma R&D Spending Trends

Geographies and TAs, China, Artificial Intelligence, Pharma Spending

Mar 17 •

Epoch 10: Beyond the Bucks - How Specialist Investors Fuel Biotech Success

Biotech Haves & Have Nots Analysis

Mar 10 •

Epoch 9: Roche Goes Digital: A Day in the Life of the Future

AI Investment Trends, Pharma AI Rankings, Roche Case Study

Mar 3 •

Epoch 8: Biotech Hiring Best Practices

Challenges, Conventional Approaches, BowtiedBiotech System

Feb 25 •

Epoch 7: Decoding Signals That Move Big Pharma Stocks

Business Model Shifts, MegaBlockbuster Products, Growth Forecasts

Feb 18 •

Epoch 6: Is Cost-Effectiveness Killing Innovation?

Recommendations for Sustainable Biopharma Innovation

Feb 11 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts